This week, within the framework of the Mobile World Congress, AstraZeneca Spain, in collaboration with Kunsen, launched the “Platón Challenge”; An initiative aimed at the innovation and entrepreneurship ecosystem that aims to support the development of projects that facilitate the diagnosis and clinical management of signs and symptoms in cancer patients.
People with cancer may present with various symptoms and signs associated with potential adverse effects derived from oncology treatments. These adverse effects may cause interruption of highly effective treatment due to the patient's negative experience or impact on his or her health condition.
Through this call, AstraZeneca Spain and Kunsen seek to identify digital health initiatives that, thanks to new technologies, help develop ideas that facilitate the identification and clinical management of adverse effects in cancer patients.
“With this challenge we want to foster innovation in digital health, while at the same time promoting the advancement of solutions that generate real impact on health and well-being,” according to Dr. Cesar Velasco, Director of Innovation and Digital Strategy at AstraZeneca in Spain. . Of people. From the public.” Along these lines, Dr. Velasco emphasized that “we are convinced that technology can help develop more precise solutions, helping to detect the emergence of adverse effects in a patient more quickly, even before the first symptoms appear. Likewise, it is possible to Technological innovation is a key ally in facilitating early treatment of adverse effects caused by medications. “Digital solutions can also help improve communication and coordination between patients, caregivers and healthcare professionals.”
For her part, Laura Colon, Director of the Oncology Department at AstraZeneca in Spain, highlighted the importance of this initiative, which combines the search for initiatives to improve the lives of people with cancer and employing talent in the health service.
In the words of Laura Colón, “This challenge arises at the initiative of the PLATÓN group, with the aim of promoting the development of initiatives that respond to the management of symptoms in cancer patients, improving treatment success and patient satisfaction at the same time.” “This time we are connecting this group of young oncologists with the health entrepreneurship and innovation ecosystem.”
For Adrian Goretxo, Director of Strategy and Development at Consen, “Health startups The digital that we have promoted these years, they have methodology, agility and knowledge, Which we believe is of great value to the health system. We're moving these tools to oncologists, so they can deliver better care with the support of technology. Quality.”
Those interested in participating in the challenge must submit their proposals on the web platform https://azone.es/actualidad/challenge-to-the-innovation-ecosystem.html After a stage After initial selection, the selected projects will participate in workshops co-organized by them Kunsen and AstraZeneca will opt for a virtual session and establish an advisory committee By oncologists, in order to validate the proposed solution from a perspective clinic. Finally, they will be invited to give a presentation in a “pitch” format before a The final evaluation committee is made up of medical experts and AstraZeneca.
The award, intended for start-ups, public or private institutions (legal entities), consists of a financial award of 5,000 euros to support the continuation of the innovative idea, as well as brand recognition, dissemination and communication of the project. Digital health of the entire innovation ecosystem. In addition, you will receive a commitment from From AstraZeneca Spain to evaluate a potential ad hoc alliance for financing and Developing the first phase of your project in our health system.
The application deadline ends March 22, 2024.
On April 10, the list of pre-selected projects for this phase will be announced. last.
On June 14, the decision on the final and winning initiative will be announced. the solution The selected project will also be published on the website http://www.astrazeneca.es.
fountain: ringing
“Beeraholic. Friend of animals everywhere. Evil web scholar. Zombie maven.”